Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash
08:30pm, Monday, 14'th Jul 2025
It's difficult to get motivated about buying a stock that's plummeted or a company that seems to be out of favor with the general investment community. But if that company has bright long-term prospec
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights
06:51pm, Friday, 11'th Jul 2025
The latest trading day saw Moderna (MRNA) settling at $33.64, representing a -1.87% change from its previous close.
MRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric Patients
12:01pm, Friday, 11'th Jul 2025
Moderna stock jumps 4.5% as the FDA grants full approval for its COVID-19 vaccine in high-risk individuals aged six months to 11 years.
This Former Meme Stock, Down 93%, is a High-Upside Buy Right Now
10:44am, Friday, 11'th Jul 2025
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago.
Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025
07:00am, Friday, 11'th Jul 2025
CAMBRIDGE, MA / ACCESS Newswire / July 11, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, August 1, 2025 to report i
FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months
02:13pm, Thursday, 10'th Jul 2025
The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.'s MRNA supplemental Biologics License Application (sBLA) for Spikevax, the company's COVID-19 vaccine, in children six months thro
Moderna gets full US approval for COVID vaccine in children 6 months and older
08:33am, Thursday, 10'th Jul 2025
The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the co
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 /
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win
07:18am, Thursday, 10'th Jul 2025
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a long-run
S&P 500 Gains and Losses Today: FICO Shares Plummet; Moderna Stock Rises
05:40pm, Tuesday, 08'th Jul 2025
Major U.S. equities indexes finished the day mixed as investors worked through the latest developments in the trade policy saga.
MRNY: Poor Performance Due To Moderna's Decline
10:38am, Monday, 07'th Jul 2025
MRNY's synthetic option strategy delivers high distributions but has led to severe capital losses, with price down over 83% in the past year. The capped upside and unlimited downside risk make MRNY un
2 Beaten-Down Stocks to Buy and Hold
07:45am, Saturday, 05'th Jul 2025
Equity markets have been volatile throughout the year. We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.
Where Will Moderna Be in 10 Years?
05:10am, Saturday, 05'th Jul 2025
A lot can happen in 10 years, and that's good news for a struggling stock like Moderna (MRNA 0.66%). Once a stock market star generating billions of dollars in coronavirus vaccine revenue, Moderna in
Why Moderna Stock Was So Healthy This Week
03:07pm, Friday, 04'th Jul 2025
Moderna (MRNA 0.66%), the next-generation healthcare company most famous for developing the Spikevax coronavirus vaccine, was an uncharacteristically popular stock. Investors piled into its shares ove
The 16 Investments I Made With My $1.8m Inheritance
01:01pm, Thursday, 03'rd Jul 2025
Key Points A Reddit user shared how he invested his $1.8 million inheritance, listing the mix of different assets he had selected. Most other posters felt he had a solid mix of different assets, inclu
